JPMorgan Chase & Co. Has $3.75 Million Stake in Ardent Health, Inc. $ARDT

JPMorgan Chase & Co. lowered its position in shares of Ardent Health, Inc. (NYSE:ARDT) by 17.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 283,061 shares of the company’s stock after selling 59,738 shares during the quarter. JPMorgan Chase & Co. owned about 0.20% of Ardent Health worth $3,751,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of ARDT. Voleon Capital Management LP acquired a new position in shares of Ardent Health in the 3rd quarter valued at about $571,000. Verition Fund Management LLC grew its stake in Ardent Health by 540.6% during the third quarter. Verition Fund Management LLC now owns 85,561 shares of the company’s stock worth $1,134,000 after purchasing an additional 72,205 shares during the period. Prelude Capital Management LLC increased its holdings in Ardent Health by 30.3% in the third quarter. Prelude Capital Management LLC now owns 18,303 shares of the company’s stock worth $243,000 after purchasing an additional 4,259 shares in the last quarter. Millennium Management LLC lifted its stake in Ardent Health by 6.6% in the third quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock valued at $16,822,000 after buying an additional 78,861 shares during the period. Finally, Bank of America Corp DE lifted its stake in Ardent Health by 2.5% in the third quarter. Bank of America Corp DE now owns 310,563 shares of the company’s stock valued at $4,115,000 after buying an additional 7,610 shares during the period.

Ardent Health Price Performance

Shares of NYSE:ARDT opened at $8.65 on Friday. Ardent Health, Inc. has a twelve month low of $8.07 and a twelve month high of $15.48. The stock’s 50 day moving average is $9.01 and its 200-day moving average is $10.43. The company has a quick ratio of 1.85, a current ratio of 1.97 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of 9.01 and a beta of 0.57.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, March 4th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.03). The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.63 billion. Ardent Health had a net margin of 2.15% and a return on equity of 14.30%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Sell-side analysts forecast that Ardent Health, Inc. will post 1.23 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. JPMorgan Chase & Co. reduced their price objective on shares of Ardent Health from $12.00 to $11.00 and set a “neutral” rating for the company in a research report on Tuesday, January 20th. UBS Group cut their target price on shares of Ardent Health from $14.50 to $14.00 and set a “buy” rating on the stock in a research note on Thursday, December 18th. Leerink Partners reduced their price target on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a report on Friday, March 6th. Mizuho decreased their price target on shares of Ardent Health from $20.00 to $12.00 and set an “outperform” rating for the company in a research note on Thursday, December 18th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Ardent Health in a report on Monday, December 29th. Seven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Ardent Health presently has a consensus rating of “Hold” and an average target price of $14.25.

Ardent Health Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.